In 2011, two independent studies (4, 5) identified the hexanucleotide G4C2 expansion in the non-coding region between exons 1a and 1b of the C9orf72 gene as the molecular key player of the FTD/ALS complex phenotype (6). The gene discussed is C9orf72; the disease is frontotemporal dementia.